Document Details
Form
Filing Date
Mar 3, 2017
Document Date
Mar 3, 2017
Form Description
Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Filing Group
Other
Company
Eledon Pharmaceuticals, Inc.
Issuer
ELEDON PHARMACEUTICALS, INC.